Today Leo checks out a new case from Sharkoon which enters a very saturated market. Does it do, and have enough to stand out?

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701 ...